Bovine Theileriosis: Welfare in East Coast Fever and Mediterranean Fever

Key Facts

• East Coast Fever (Theileria parva) is endemic in eastern and central Africa, killing millions of cattle annually
• Mediterranean theileriosis (T. annulata) affects dairy cattle in southern Europe, North Africa, and the Middle East
• Clinical signs include high fever, enlarged lymph nodes, respiratory distress, and rapid deterioration
• Without treatment, mortality in naive animals can exceed 90% for East Coast Fever
• Buparvaquone treatment (for ECF) is effective when given early in the disease course

Welfare Considerations

Theileriosis causes severe acute suffering. East Coast Fever progresses rapidly over 1-2 weeks from subtle signs to profound illness: diarrhea, respiratory distress, anemia, and terminal complications occur quickly without treatment. The welfare window for effective treatment is narrow — delayed diagnosis dramatically worsens both outcome and duration of suffering. In East Africa, where subsistence farmers depend on cattle for survival, losing animals to ECF represents catastrophic personal loss alongside animal welfare harm. The Infection and Treatment Method (ITM) vaccine for ECF has transformed welfare outcomes in some areas, providing protection that previously required costly pharmaceuticals.

What You Can Do

• Support international animal health programs working on ECF vaccination and treatment access in Africa
• Advocate for tick control infrastructure and veterinary service access in ECF-endemic regions
• Implement rigorous tick control programs in T. annulata endemic regions to prevent infection
• Recognize early signs: fever, enlarged lymph nodes, nasal discharge — early treatment is life-saving
• Support research into improved, stable, and affordable vaccines for theileriosis in endemic countries